ECO ANIMAL HEALTH GROUP PLC Logo

ECO ANIMAL HEALTH GROUP PLC

Develops and markets pharmaceuticals and biologicals for pig and poultry health.

EAH | IL

Overview

Corporate Details

ISIN(s):
GB0005056469 (+2 more)
LEI:
2138009XN9DJ3YP7OB55
Country:
United Kingdom
Address:
THE GRANGE, 100 HIGH STREET, N14 6BN LONDON

Description

ECO Animal Health Group is a global company specializing in the development, registration, and marketing of pharmaceutical and biological products for animal health. The company's primary focus is on improving the health, welfare, and productivity of pigs and poultry by addressing economically significant respiratory and enteric diseases. Its key product is Aivlosin®, a macrolide antibiotic also marketed as Valosin®. Through its dedicated research and development, the company creates innovative solutions, including vaccines and other pharmaceuticals, to support sustainable and safe food production. ECO Animal Health operates worldwide, leveraging a global network of distributors and direct market presence.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-09 19:10
Holding(s) in Company
English 43.1 KB
2025-12-04 15:20
Director/PDMR Shareholding
English 23.7 KB
2025-12-01 08:25
Results for the six months ended 30 September 2025
English 379.7 KB
2025-11-20 11:00
Replacement: Notice of Results
English 15.1 KB
2025-11-20 08:25
Notice of Results
English 14.9 KB
2025-11-10 08:25
EMA Positive Opinion Received for ECOVAXXIN® MS
English 16.2 KB
2025-10-01 08:00
Head of Global R&D
English 12.1 KB
2025-08-21 13:29
Result of General Meeting
English 12.4 KB
2025-08-13 08:00
Block Listing Return
English 17.8 KB
2025-08-06 18:09
Holding(s) in Company
English 25.3 KB
2025-07-17 08:00
Holding(s) in Company
English 40.5 KB
2025-07-15 14:00
Director/PDMR Shareholding
English 22.8 KB
2025-07-14 08:00
Results for the year ended 31 March 2025
English 1.2 MB
2025-07-08 17:10
Notice of General Meeting and Notice of Results
English 15.3 KB
2025-03-13 08:00
R&D Day
English 11.7 KB

Automate Your Workflow. Get a real-time feed of all ECO ANIMAL HEALTH GROUP PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ECO ANIMAL HEALTH GROUP PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ECO ANIMAL HEALTH GROUP PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.